Virginia Retirement Systems’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
62,748
-8,700
| -12% | -$188K | 0.01% | 503 |
|
|
2025
Q1 | $1.19M | Buy |
+71,448
| New | +$1.19M | 0.01% | 521 |
|
|
2023
Q3 | $882K | Sell |
42,300
-15,100
| -26% | -$315K | 0.01% | 544 |
|
|
2023
Q2 | $1.37M | Buy |
57,400
+19,700
| +52% | +$472K | 0.01% | 457 |
|
|
2023
Q1 | $710K | Buy |
37,700
+8,300
| +28% | +$156K | 0.01% | 640 |
|
|
2022
Q4 | $468K | Sell |
29,400
-4,300
| -13% | -$68.5K | ﹤0.01% | 845 |
|
|
2022
Q3 | $551K | Buy |
+33,700
| New | +$551K | 0.01% | 781 |
|
|
2022
Q1 | $862K | Sell |
35,600
-2,000
| -5% | -$48.4K | 0.01% | 693 |
|
|
2021
Q4 | $878 | Buy |
37,600
+200
| +0.5% | +$5 | 0.01% | 703 |
|
|
2021
Q3 | $621K | Buy |
37,400
+6,700
| +22% | +$111K | 0.01% | 754 |
|
|
2021
Q2 | $749K | Buy |
30,700
+16,400
| +115% | +$400K | 0.01% | 740 |
|
|
2021
Q1 | $369K | Buy |
14,300
+1,700
| +13% | +$43.9K | ﹤0.01% | 951 |
|
|
2020
Q4 | $674K | Sell |
12,600
-15,100
| -55% | -$808K | 0.01% | 743 |
|
|
2020
Q3 | $1.14M | Sell |
27,700
-3,000
| -10% | -$124K | 0.01% | 511 |
|
|
2020
Q2 | $1.49M | Buy |
30,700
+3,300
| +12% | +$160K | 0.02% | 457 |
|
|
2020
Q1 | $1.16M | Buy |
27,400
+20,900
| +322% | +$883K | 0.02% | 495 |
|
|
2019
Q4 | $278K | Buy |
+6,500
| New | +$278K | ﹤0.01% | 1050 |
|